Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Spontaneous Growth and Effect of Early Therapy with Calcitriol and Phosphate in X-linked Hypophosphatemic Rickets.

Cagnoli M, Richter R, Böhm P, Knye K, Empting S, Mohnike K.

Pediatr Endocrinol Rev. 2017 Nov;15(Suppl 1):119-122. doi: 10.17458/per.vol15.2017.crb.spontaneousgrowtheffect.

PMID:
29292875
2.

Alternative low-cost approach to the synthesis of magnetic iron oxide nanoparticles by thermal decomposition of organic precursors.

Perez De Berti IO, Cagnoli MV, Pecchi G, Alessandrini JL, Stewart SJ, Bengoa JF, Marchetti SG.

Nanotechnology. 2013 May 3;24(17):175601. doi: 10.1088/0957-4484/24/17/175601. Epub 2013 Apr 3.

PMID:
23548801
3.

Highly anisotropic distribution of iron nanoparticles within MCM-41 Mesoporous Silica.

Moreno MS, Weyland M, Midgley PA, Bengoa JF, Cagnoli MV, Gallegos NG, Alvarez AM, Marchetti SG.

Micron. 2006;37(1):52-6. Epub 2005 Jul 14.

PMID:
16084103
4.

Step-down approach using either cyclosporin A or methotrexate as maintenance therapy in early rheumatoid arthritis.

Marchesoni A, Battafarano N, Arreghini M, Pellerito R, Cagnoli M, Prudente P, Cerase A, Priolo F, Tosi S.

Arthritis Rheum. 2002 Feb;47(1):59-66.

5.

Antiproliferative activity and interactions with cell-cycle related proteins of the organotin compound triethyltin(IV)lupinylsulfide hydrochloride.

Barbieri F, Sparatore F, Cagnoli M, Bruzzo C, Novelli F, Alama A.

Chem Biol Interact. 2001 Mar 14;134(1):27-39.

PMID:
11248220
6.

Cytotoxicity in vitro and preliminary antitumor activity in vivo of a novel organotin compound.

Barbieri F, Viale M, Sparatore F, Favre A, Cagnoli M, Bruzzo C, Novelli F, Alama A.

Anticancer Res. 2000 Mar-Apr;20(2A):977-80.

PMID:
10810384
7.

Increased cyclin D1 expression is associated with features of malignancy and disease recurrence in ovarian tumors.

Barbieri F, Cagnoli M, Ragni N, Foglia G, Bruzzo C, Pedullà F, Alama A.

Clin Cancer Res. 1999 Jul;5(7):1837-42.

8.

[Rotavirus laboratory network: results after one year of observation].

Bok K, Castagnaro NC, Diaz NE, Borsa A, Cagnoli MR, Nates S, Yudowsky S, Espul C, Cuello H, Fay O, Brunet B, Ues OC, Santoro R, Grinstein S, Gonzalez F, Miceli I, Gomez JA.

Rev Argent Microbiol. 1999 Jan-Mar;31(1):1-12. Spanish.

PMID:
10327454
9.

Control of cyclin D1 expression by antisense oligonucleotides in three ovarian cancer cell lines.

Cagnoli M, Barbieri F, Bruzzo C, Alama A.

Gynecol Oncol. 1998 Sep;70(3):372-7.

PMID:
9790790
10.

Synthesis and biological activity of gold and tin compounds in ovarian cancer cells.

Cagnoli M, Alama A, Barbieri F, Novelli F, Bruzzo C, Sparatore F.

Anticancer Drugs. 1998 Aug;9(7):603-10.

PMID:
9773804
11.

Antisense oligonucleotides as therapeutic agents.

Alama A, Barbieri F, Cagnoli M, Schettini G.

Pharmacol Res. 1997 Sep;36(3):171-8. Review.

PMID:
9367660
12.

Comparison of total alkaline phosphatase and three assays for bone-specific alkaline phosphatase in childhood and adolescence.

Rauch F, Middelmann B, Cagnoli M, Keller KM, Schönau E.

Acta Paediatr. 1997 Jun;86(6):583-7.

PMID:
9202791
13.

Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets.

Francis F, Strom TM, Hennig S, Böddrich A, Lorenz B, Brandau O, Mohnike KL, Cagnoli M, Steffens C, Klages S, Borzym K, Pohl T, Oudet C, Econs MJ, Rowe PS, Reinhardt R, Meitinger T, Lehrach H.

Genome Res. 1997 Jun;7(6):573-85. No abstract available.

14.

Expression of cyclin D1 correlates with malignancy in human ovarian tumours.

Barbieri F, Cagnoli M, Ragni N, Pedullà F, Foglia G, Alama A.

Br J Cancer. 1997;75(9):1263-8.

15.

Establishment and characterization of three new cell lines derived from the ascites of human ovarian carcinomas.

Alama A, Barbieri F, Favre A, Cagnoli M, Noviello E, Pedullà F, Viale M, Foglia G, Ragni N.

Gynecol Oncol. 1996 Jul;62(1):82-8.

PMID:
8690298
16.

Inhibition of DNA polymerase alpha expression and cell growth, a possible triple helix mechanism.

Alama A, Barbieri F, Cagnoli M, Mazzei M, Grandi T, Nicolin A.

Antisense Nucleic Acid Drug Dev. 1996 Summer;6(2):95-101.

PMID:
8843323
17.

Feasibility of thymidine labelling index on fine needle aspirates from breast cancer: comparison with surgical samples.

Barbieri F, Parodi G, Massa T, Cagnoli M, Barbi G, Imperiale A, Alama A.

Anticancer Res. 1994 Sep-Oct;14(5A):1973-7.

PMID:
7847836
18.

Combined steroid, methotrexate and chlorambucil therapy for steroid-resistant dermatomyositis.

Cagnoli M, Marchesoni A, Tosi S.

Clin Exp Rheumatol. 1991 Nov-Dec;9(6):658-9. No abstract available.

PMID:
1764849
19.

Injectable gold dermatitis and proteinuria: retreatment with auranofin.

Tosi S, Cagnoli M, Guidi G, Murelli M, Messina K, Colombo B.

Int J Clin Pharmacol Res. 1985;5(4):265-8.

PMID:
2932399
20.

Painful gynecomastia with ranitidine.

Tosi S, Cagnoli M.

Lancet. 1982 Jul 17;2(8290):160. No abstract available.

PMID:
6123872

Supplemental Content

Loading ...
Support Center